Choi S, Park H, Choi E, Jung K, Lee J
Sci Rep. 2022; 12(1):14111.
PMID: 35982155
PMC: 9388645.
DOI: 10.1038/s41598-022-18340-3.
Wyatt K, Sarr D, Sakamoto K, Watford W
PLoS One. 2022; 17(1):e0262832.
PMID: 35051238
PMC: 8775564.
DOI: 10.1371/journal.pone.0262832.
Morsy Y, Brillant N, Franc Y, Scharl M, Wawrzyniak M, The Swiss Ibd Cohort Study Group
Cells. 2021; 10(12).
PMID: 34944097
PMC: 8700574.
DOI: 10.3390/cells10123589.
Latha K, Jamison K, Watford W
Front Immunol. 2021; 12:738490.
PMID: 34691044
PMC: 8529111.
DOI: 10.3389/fimmu.2021.738490.
Sagwal S, Prasad R, Kaur J, Singh M
Mol Cell Biochem. 2021; 476(7):2869-2876.
PMID: 33740185
DOI: 10.1007/s11010-021-04051-2.
Foot-and-Mouth Disease Virus Capsid Protein VP1 Antagonizes TPL2-Mediated Activation of the IRF3/IFN-β Signaling Pathway to Facilitate the Virus Replication.
Hao J, Shen C, Wei N, Yan M, Zhang X, Xu G
Front Immunol. 2021; 11:580334.
PMID: 33488582
PMC: 7821752.
DOI: 10.3389/fimmu.2020.580334.
TRAF2 regulates T cell immunity by maintaining a Tpl2-ERK survival signaling axis in effector and memory CD8 T cells.
Xie X, Zhu L, Jie Z, Li Y, Gu M, Zhou X
Cell Mol Immunol. 2020; 18(9):2262-2274.
PMID: 33203937
PMC: 8429472.
DOI: 10.1038/s41423-020-00583-7.
Toll-Like Receptor 2-Tpl2-Dependent ERK Signaling Drives Inverse Interleukin 12 Regulation in Dendritic Cells and Macrophages.
Groft S, Nagy N, Boom W, Harding C
Infect Immun. 2020; 89(1).
PMID: 33077627
PMC: 7927937.
DOI: 10.1128/IAI.00323-20.
Tumor progression locus 2 (TPL2) in tumor-promoting Inflammation, Tumorigenesis and Tumor Immunity.
Njunge L, Estania A, Guo Y, Liu W, Yang L
Theranostics. 2020; 10(18):8343-8364.
PMID: 32724474
PMC: 7381748.
DOI: 10.7150/thno.45848.
Activation Receptor-Dependent IFN-γ Production by NK Cells Is Controlled by Transcription, Translation, and the Proteasome.
Piersma S, Pak-Wittel M, Lin A, Plougastel-Douglas B, Yokoyama W
J Immunol. 2019; 203(7):1981-1988.
PMID: 31444264
PMC: 6760998.
DOI: 10.4049/jimmunol.1900718.
Transcription factors STAT-4, STAT-6 and CREB regulate Th1/Th2 response in leprosy patients: effect of M. leprae antigens.
Upadhyay R, Dua B, Sharma B, Natrajan M, Jain A, Kithiganahalli Narayanaswamy B
BMC Infect Dis. 2019; 19(1):52.
PMID: 30642265
PMC: 6332553.
DOI: 10.1186/s12879-018-3601-z.
Severe Dermatitis Associated with Spontaneous Infection in Mice.
Acuff N, LaGatta M, Nagy T, Watford W
Comp Med. 2017; 67(4):344-349.
PMID: 28830581
PMC: 5557206.
Tpl2 Promotes Innate Cell Recruitment and Effector T Cell Differentiation To Limit Citrobacter rodentium Burden and Dissemination.
Acuff N, Li X, Latha K, Nagy T, Watford W
Infect Immun. 2017; 85(10).
PMID: 28760932
PMC: 5607429.
DOI: 10.1128/IAI.00193-17.
TPL-2 restricts Ccl24-dependent immunity to Heligmosomoides polygyrus.
Kannan Y, Entwistle L, Pelly V, Perez-Lloret J, Walker A, Ley S
PLoS Pathog. 2017; 13(7):e1006536.
PMID: 28759611
PMC: 5560741.
DOI: 10.1371/journal.ppat.1006536.
Map3k8 controls granulocyte colony-stimulating factor production and neutrophil precursor proliferation in lipopolysaccharide-induced emergency granulopoiesis.
Sanchez A, Relano C, Carrasco A, Contreras-Jurado C, Martin-Duce A, Aranda A
Sci Rep. 2017; 7(1):5010.
PMID: 28694430
PMC: 5503936.
DOI: 10.1038/s41598-017-04538-3.
Tpl2 promotes neutrophil trafficking, oxidative burst, and bacterial killing.
Acuff N, Li X, Elmore J, Rada B, Watford W
J Leukoc Biol. 2017; 101(6):1325-1333.
PMID: 28356348
PMC: 5433858.
DOI: 10.1189/jlb.3A0316-146R.
The serum protein profile of early parity which induces protection against breast cancer.
Bracamontes C, Lopez-Valdez R, Subramani R, Arumugam A, Nandy S, Rajamanickam V
Oncotarget. 2016; 7(50):82538-82553.
PMID: 27769065
PMC: 5347712.
DOI: 10.18632/oncotarget.12757.
TPL-2 Regulates Macrophage Lipid Metabolism and M2 Differentiation to Control TH2-Mediated Immunopathology.
Kannan Y, Perez-Lloret J, Li Y, Entwistle L, Khoury H, Papoutsopoulou S
PLoS Pathog. 2016; 12(8):e1005783.
PMID: 27487182
PMC: 4972396.
DOI: 10.1371/journal.ppat.1005783.
Tumor progression locus 2 reduces severe allergic airway inflammation by inhibiting Ccl24 production in dendritic cells.
Kannan Y, Li Y, Coomes S, Okoye I, Pelly V, Sriskantharajah S
J Allergy Clin Immunol. 2016; 139(2):655-666.e7.
PMID: 27484038
PMC: 5292997.
DOI: 10.1016/j.jaci.2016.05.031.
Tumor Progression Locus 2 (Tpl2) Activates the Mammalian Target of Rapamycin (mTOR) Pathway, Inhibits Forkhead Box P3 (FoxP3) Expression, and Limits Regulatory T Cell (Treg) Immunosuppressive Functions.
Li X, Acuff N, Peeks A, Kirkland R, Wyatt K, Nagy T
J Biol Chem. 2016; 291(32):16802-15.
PMID: 27261457
PMC: 4974392.
DOI: 10.1074/jbc.M116.718783.